Head-to-head · Cost-Efficiency Index
Go Vida Plena vs VirtualCare2Go
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Go Vida Plena
Cost-first shoppers who want spanish-speaking patients wanting GLP-1 access with culturally-tailored, Spanish-first support.
Visit Go Vida PlenaVirtualCare2Go
Shoppers near Dallas-Fort Worth who want a bundled per-visit price rather than a per-drug breakdown.
Visit VirtualCare2GoThe verdict
Go Vida Plena and VirtualCare2Go tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Go Vida Plena (ranked #147, a hair above #154) — Cost-first shoppers who want spanish-speaking patients wanting GLP-1 access with culturally-tailored, Spanish-first support. But VirtualCare2Go is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Go Vida Plena.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Go Vida Plena | VirtualCare2Go |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $179/mo (annual plan, compounded) | $279/mo (bundle, compounded) |
| Tirzepatide / mo | $269/mo (annual plan, compounded) | $629/mo (bundle, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $3,348 |
| Tirzepatide / yr (modeled) | $3,228 | $7,548 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #147 | #154 |
Go Vida Plena
66/100Where the value is
- Genuinely bilingual, Spanish-first platform serving an underserved market segment
- Offers both injectable and oral GLP-1 formulations
- Explicit, plain-language disclosure that compounded drugs are not FDA-approved
The tradeoffs
- Lowest advertised prices ($179/$269) require an annual plan commitment, not simple month-to-month billing
- Per-day price framing ('~$6/day') is used on the homepage, a common technique to understate the real monthly cost
VirtualCare2Go
66/100Where the value is
- Three distinct price points let a budget-conscious shopper choose compounded ($279) over the bundled injection tier ($629)
- A stand-alone $99.99 consult-only option exists for shoppers who want to fill the prescription at their own pharmacy
- Clear plain-language inclusion statements (consultation, medication, shipping) attached to each tier
The tradeoffs
- The $629 'Weight Loss Injections' tier prices semaglutide, liraglutide, and tirzepatide identically and does not disclose whether tirzepatide specifically costs more — a real gap for a comparison site trying to isolate a tirzepatide price
- No LegitScript badge found anywhere on the site, where the other rows in this batch carry one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.